In the form of a 'nasal spray', tiny gold particles act as carriers, delivering a treatment directly to the brain: developed by scientists at the Università Rome campus/Fondazione Policlinico ...
Journal of Bioresources and Bioproducts reports that a phenol-rich, low-molecular lignin fraction (F3) obtained by simple ...
Tiny gold particles that act as carriers for lithium can be delivered directly to the brain in the form of a nasal spray.
Orelabrutinib, a highly selective CNS-penetrant, oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with best-in-class potential now ...
Ordinary human cells, not just neurons, respond more strongly to memory signals when they arrive in spaced bursts rather than ...
While Bruton’s tyrosine kinase inhibitors are often hailed as the next big breakthrough in multiple sclerosis, Immunic ...
A study in Advanced Science has pinpointed how a high-salt diet can lead to cognitive decline. Researchers found excess salt ...
Erasca, Inc. shifts to innovative RAS inhibitors with strong cash runway. Click for why ERAS stock is rated Hold and when to ...
Elderberry juice intake triggers metabolic gene expression changes, enhancing glucose control and fat oxidation in overweight ...
Scientists found mushrooms make psilocybin using two different enzyme toolkits. The same molecule forms by separate paths.
TipRanks on MSN
Aclaris Therapeutics to host R&D Day on October 14
Aclaris Therapeutics (ACRS) will host it’s 2025 R&D Day in Midtown, New York on Tuesday, October 14, 2025 at 8:00 AM ET to discuss the Company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results